Health

Moderna to Apply for FDA Authorization of Coronavirus Vaccine

Moderna will apply Monday to Food and Drug Administration for emergency authorization for its coronavirus vaccine, the Cambridge, Mass.-based biotechnology giant announced.

Moderna will ask the FDA to review an expanded data set showing the vaccine 94.1% effective at stopping the coronavirus and 100% effective at preventing severe instances of the virus.

Moderna is expected to have about 20 million doses of its vaccine in the U.S. by the end of the year and is set to create 500 million to one billion doses worldwide in 2021, the drugmaker said in a release Monday.

Earlier this month, Pfizer became the first company to apply to the FDA for approval of a coronavirus vaccine, touting the 95% effectiveness of its candidate, which it developed with German partner BioNTech.

The FDA is expected to review Moderna and Pfizer’s applications in December, CNN reported.

As of Monday, the U.S. has approximately 13.4 million coronavirus cases and 267,000 related deaths — both tops globally — according to a Johns Hopkins University tracker.

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker